China Universal Asset Management »

Pyxis Oncology shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Pyxis Oncology (PYXS) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Pyxis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Pyxis Oncology held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pyxis Oncology by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $24k 11k 2.22
2025-06-30 $14k 12k 1.10
2025-03-31 $12k 12k 0.98
2024-12-31 $20k 13k 1.56

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Alphabet Inc-cl A Common Stock (GOOGL)
Meta Platforms Inc-class A Common Stock (META)
Netflix Common Stock (NFLX)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Gilead Sciences Common Stock (GILD)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl C Common Stock (GOOG)
Palantir Technologies Inc-a Common Stock (PLTR)
Applovin Corp-class A Common Stock (APP)

View all positions for China Universal Asset Management

Top funds holding Pyxis Oncology

Pfizer
Laurion Capital Management
Tang Capital Management
Vanguard Group
Perceptive Advisors
Palo Alto Investors
Millennium Management
Stempoint Capital
BlackRock
Renaissance Technologies
Geode Capital Management
683 Capital Management
Driehaus Capital Management
UBS Group
Citadel Advisors

View all funds holding Pyxis Oncology